ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
Emergence and characterization of a novel ST627-KL8 carbapenem-resistant Klebsiella pneumoniae lineage associated with ICU transmission in a tertiary hospital, China
Provisionally accepted- 1Department of Clinical Laboratory, Zhangjiagang First People's Hospital, Suzhou, China
- 2Nanjing Agricultural University College of Veterinary Medicine, Nanjing, China
- 3Department of Clinical Laboratory, Second Affiliated Hospital of Soochow University, Suzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Introduction: Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a serious threat to public health. We characterized a rarely reported ST627-KL8 CRKP lineage associated with intensive care unit (ICU) transmission. Methods: Three isolates (ZJG29565, ZJG30140, and ZJG30146) were obtained from three patients in the ICU and subjected to antimicrobial susceptibility testing. Whole-genome sequencing (WGS) was performed to determine genomic characteristics, phylogenetic relationships, and plasmid content, followed by assessments of mucoviscosity, capsule quantification, serum resistance, and bacterial virulence using a Galleria mellonella (G. mellonella) infection model. Additionally, bacterial capsule morphology was observed via transmission electron microscopy (TEM). Results: SNP analysis (≤5 SNPs) confirmed clonal transmission within the ICU. Phylogenetic analysis placed ST627-KL8 as a distinct lineage closely related to ST14. All isolates carried an IncFIIK34 plasmid encoding blaKPC-2, consistent with their carbapenem-resistant phenotype. Phenotypic assays—including TEM, mucoviscosity testing, serum resistance, and uronic acid quantification—demonstrated a thinner capsule and reduced mucoviscosity compared with the KL2 reference strain. In the Galleria mellonella model, ST627-KL8 exhibited intermediate virulence (66.7–76.7% survival), between the hypervirulent K. pneumoniae ATCC 43816 strain (30.0%) and the low-virulence K. pneumoniae ATCC 700603 strain (96.7%). Discussion: This study identified a novel ST627-KL8 CRKP clone with intermediate virulence, consistent with its reduced capsule phenotype and lack of classical hypervirulence genes. These features, together with the subtle clinical presentations, may contribute to reduced clinical vigilance and delayed optimization of antimicrobial therapy. Importantly, ST627-KL8 CRKP carried the IncFIIK34 blaKPC-2 plasmid, which has been reported to exhibit high conjugation frequency, posing a significant challenge in clinical settings.
Keywords: Carbapenem-resistance, IncFIIK34 plasmid, Klebsiella pneumoniae, Nosocomial infection, ST627-KL8 type
Received: 12 Oct 2025; Accepted: 11 Dec 2025.
Copyright: © 2025 Pang, Xu, Zheng, Ding, Zhang, Du and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Long Chen
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
